- Accession Number:
- Form Type:
- Zero Holdings:
- Publication Time:
- 2011-03-18 16:27:41
- Reporting Period:
- Filing Date:
- Filing Date Changed:
- Accepted Time:
- 2011-03-18 17:27:41
- Original Submission Date:
|Cik||Name||Symbol||Sector (SIC)||IRS No|
|1325879||Aveo Pharmaceuticals Inc||AVEO||Pharmaceutical Preparations (2834)||000000000|
|Cik||Name||Reported Address||Insider Title||Director||Officer||Large Shareholder||Other|
|1486429||Elan Ezickson||C/o Aveo Pharmaceuticals, Inc. |
75 Sidney Street
Cambridge MA 02139
|Chief Business Officer||No||Yes||No||No|
|Sec. Name||Acquisiton - Disposition||Date||Amount||Price||Remaning Holdings|
|Equity Swap Involved||Form Type||Code||Nature of Ownership||Explanation|
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 2, 2010.
- The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.40 to $14.51, inclusive. The reporting person undertakes to provide AVEO Pharmaceuticals, Inc., any security holder of AVEO Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).